The nation of Zimbabwe has declined a major US health deal valued at $367m (£272m) spanning five years over the United States' demand for sensitive information.
This rejection came to light following a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
A government spokesperson has since clarified that the US was demanding access to biological samples for scientific study and commercial purposes but was unwilling to guarantee the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for more negotiations to find a agreement acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Context
This rejection follows a similar case in Kenya, where a high court halted a related health funding agreement after concerns were raised about the security of Kenyans' health data.
Since returning to office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and accountability.
According to reports, 16 nations in Africa have so far signed these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, without any equivalent promise of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.
"Effectively, our nation would provide the raw materials for medical research without any assurance that the end products would be accessible to our citizens should a future pandemic emerge."
Sovereignty and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending structures previously established via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how subsequent collaboration might be designed in a manner that respects the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but suggested that negotiations must proceed given that much of the country's Aids initiatives depended on international support.
"Where specific concerns arise, including those relating to data governance or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it said.
The halted deal emphasises the ongoing debate between receiving vital foreign assistance and protecting local interests in an ever more data-driven world.